Users of this system, can login to view this document.
Login
Enter the following information to request a copy of the document from the responsible person.
A Phase I, Open-Label, Dose-Finding Study of GSK2636771, a PI3Kβ Inhibitor, Administered with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer.
This email address is used for sending the document.